1. Academic Validation
  2. PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer

PSMA-targeted radiopharmaceutical therapy in patients with metastatic castration-resistant prostate cancer

  • Lancet. 2021 Feb 27;397(10276):768-769. doi: 10.1016/S0140-6736(21)00349-4.
Thomas A Hope 1 Jeremie Calais 2
Affiliations

Affiliations

  • 1 Department of Radiology and Biomedical Imaging and Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA; Department of Radiology and Biomedical Imaging, San Francisco VA Medical Center, San Francisco, CA, USA. Electronic address: [email protected].
  • 2 Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine and Institute of Urologic Oncology, University of California Los Angeles, Los Angeles, CA, USA.
Figures
Products